Wed, Jul 23, 2014, 2:17 PM EDT - U.S. Markets close in 1 hr 43 mins

Recent

% | $
Click the to save as a favorite.

Johnson & Johnson Message Board

  • mirror_world_man mirror_world_man Sep 21, 2013 12:24 AM Flag

    Invokana Gets Positive CHMP Opinion

    INVOKANA® (canagliflozin) Receives Positive Opinion Recommending Approval in the European Union for the Treatment of Adults with Type 2 Diabetes Mellitus1 September 20, 2013 09:14 AM Eastern Daylight Time
    BEERSE, Belgium--(BUSINESS WIRE)--Janssen-Cilag International NV (Janssen) announced today that the Committee for Medicinal Products for Human Use (CHMP) has granted a positive opinion recommending approval of INVOKANA® (canagliflozin) in the European Union for the treatment of adults with type 2 diabetes mellitus, to improve glycaemic control.1 Canagliflozin is an oral, once-daily medication, which belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors.

 
JNJ
102.24-0.23(-0.22%)2:17 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.